DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Baldari S, Ferraù F, Alafaci C. et al.
First demonstration of the effectiveness of peptide receptor radionuclide therapy (PRRT) with 111In-DTPA-octreotide in a giant PRL-secreting pituitary adenoma resistant to conventional treatment.
Pituitary 2012; (15) S57-S60
Access:
We do not assume any responsibility for the contents of the web pages of other providers.